{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T09:17:11Z","timestamp":1770887831506,"version":"3.50.1"},"reference-count":52,"publisher":"China Science Publishing & Media Ltd.","issue":"2","content-domain":{"domain":["engine.scichina.com"],"crossmark-restriction":false},"short-container-title":["ABBS"],"published-print":{"date-parts":[[2026,2,1]]},"DOI":"10.3724\/abbs.2025197","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T09:04:51Z","timestamp":1760519091000},"page":"437-452","update-policy":"https:\/\/doi.org\/10.1360\/scp-crossmark-policy-page","source":"Crossref","is-referenced-by-count":0,"title":["The prognostic marker NRIP1 is associated with tumor progression and immune infiltration in acute myeloid leukemia"],"prefix":"10.3724","volume":"58","author":[{"given":"Xunxun","family":"Zhu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingyan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingjing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanling","family":"Tao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2026","published-online":{"date-parts":[[2025,11,4]]},"reference":[{"key":"CITATION1","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1007\/s00277-023-05372-6","volume":"102","author":"Niu D","year":"2023","unstructured":"Niu D, Zhao Y, Wang J, Ye E, Huang J, Liu J, Huang X. Secular trend in disease burden of leukemia and its subtypes in China from 1990 to 2019 and its projection in 25 years. Ann Hematol, 2023, 102: 2375-2386.","journal-title":"Ann Hematol"},{"key":"CITATION2","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.3390\/cancers14051164","volume":"14","author":"Nitika","year":"2022","unstructured":"Nitika, Wei J, Hui AM. Role of biomarkers in FLT3 AML. Cancers, 2022, 14: 1164.","journal-title":"Cancers"},{"key":"CITATION3","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s40164-020-00161-7","volume":"9","author":"Yu J","year":"2020","unstructured":"Yu J, Li Y, Zhang D, Wan D, Jiang Z. Clinical implications of recurrent gene mutations in acute myeloid leukemia. Exp Hematol Oncol, 2020, 9: 4.","journal-title":"Exp Hematol Oncol"},{"key":"CITATION4","doi-asserted-by":"publisher","first-page":"19811","DOI":"10.1038\/s41598-024-65345-1","volume":"14","author":"Miao P","year":"2024","unstructured":"Miao P, Yu J, Chen Z, Qian S, Chen C. Establishment and verification of a TME prognosis scoring model based on the acute myeloid leukemia single-cell transcriptome. Sci Rep, 2024, 14: 19811.","journal-title":"Sci Rep"},{"key":"CITATION5","doi-asserted-by":"publisher","first-page":"811144","DOI":"10.3389\/fimmu.2022.811144","volume":"13","author":"Menter T","year":"2022","unstructured":"Menter T, Tzankov A. Tumor microenvironment in acute myeloid leukemia: adjusting niches. Front Immunol, 2022, 13: 811144.","journal-title":"Front Immunol"},{"key":"CITATION6","doi-asserted-by":"publisher","first-page":"3741","DOI":"10.1002\/j.1460-2075.1995.tb00044.x","volume":"14","author":"Cavaill\u00e8s V","year":"1995","unstructured":"Cavaill\u00e8s V, Dauvois S, L\u2032Horset F, Lopez G, Hoare S, Kushner PJ, Parker MG. Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor. EMBO J, 1995, 14: 3741-3751.","journal-title":"EMBO J"},{"key":"CITATION7","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1002\/ijc.35405","volume":"157","author":"Jalaguier S","year":"2025","unstructured":"Jalaguier S, Kuehn A, Petitpas C, Dulom A, Jacquemont R, Assi C, Sixou S. The transcription factorRIP140 regulates interferon \u03b3 signaling in breast cancer. Intl J Cancer, 2025, 157: 170-182.","journal-title":"Intl J Cancer"},{"key":"CITATION8","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1007\/s00018-022-04277-3","volume":"79","author":"Jacquier V","year":"2022","unstructured":"Jacquier V, Gitenay D, Fritsch S, Bonnet S, Gy\u0151rffy B, Jalaguier S, Linares LK. RIP140 inhibits glycolysis-dependent proliferation of breast cancer cells by regulating GLUT3 expression through transcriptional crosstalk between hypoxia induced factor and p53. Cell Mol Life Sci, 2022, 79: 270.","journal-title":"Cell Mol Life Sci"},{"key":"CITATION9","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1002\/1878-0261.13626","volume":"18","author":"Sfeir N","year":"2024","unstructured":"Sfeir N, Kajdan M, Jalaguier S, Bonnet S, Teyssier C, Pyrdziak S, Yuan R. RIP140 regulates transcription factor HES1 oscillatory expression and mitogenic activity in colon cancer cells. Mol Oncol, 2024, 18: 1510-1530.","journal-title":"Mol Oncol"},{"key":"CITATION10","doi-asserted-by":"publisher","first-page":"2971","DOI":"10.3892\/or.2017.5551","volume":"37","author":"Hu YC","year":"2017","unstructured":"Hu YC, Yi ZJ, Zhou Y, Li PZ, Liu ZJ, Duan SG, Gong JP. Overexpression of RIP140 suppresses the malignant potential of hepatocellular carcinoma by inhibiting NF-\u03baB-mediated alternative polarization of macrophages. Oncol Rep, 2017, 37: 2971-2979.","journal-title":"Oncol Rep"},{"key":"CITATION11","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13045-015-0116-6","volume":"8","author":"Lapierre M","year":"2015","unstructured":"Lapierre M, Castet-Nicolas A, Gitenay D, Jalaguier S, Teyssier C, Bret C, Cartron G. Expression and role of RIP140\/NRIP1 in chronic lymphocytic leukemia. J Hematol Oncol, 2015, 8: 20.","journal-title":"J Hematol Oncol"},{"key":"CITATION12","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/s41698-023-00485-7","volume":"7","author":"Miyazaki B","year":"2023","unstructured":"Miyazaki B, Ueno T, Sugiyama M, Kojima S, Arakawa A, Tao K, Tanimura K. Promoter swapping of truncated PDGFRB drives Ph-like acute lymphoblastic leukemia. npj Precis Onc, 2023, 7: 132.","journal-title":"npj Precis Onc"},{"key":"CITATION13","doi-asserted-by":"publisher","first-page":"lqae117","DOI":"10.1093\/nargab\/lqae117","volume":"6","author":"Ruffl\u00e9 F","year":"2024","unstructured":"Ruffl\u00e9 F, Reboul J, Boureux A, Guibert B, Bessi\u00e8re C, Silva R, Jourdan E. Effective requesting method to detect fusion transcripts in chronic myelomonocytic leukemia RNA-seq. NAR Genomics BioInf, 2024, 6: lqae117.","journal-title":"NAR Genomics BioInf"},{"key":"CITATION14","doi-asserted-by":"publisher","first-page":"597","DOI":"10.3724\/abbs.2024022","volume":"56","author":"Jia Y","year":"2024","unstructured":"Jia Y, Li X, Chen L, Li L, Zhang S, Huang W, Zhang H. AHR signaling pathway mediates mitochondrial oxidative phosphorylation which leads to cytarabine resistance. Acta Biochim Biophys Sin, 2024, 56: 597-606.","journal-title":"Acta Biochim Biophys Sin"},{"key":"CITATION15","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"Yu G","year":"2012","unstructured":"Yu G, Wang LG, Han Y, He QY. clusterProfiler: an r package for comparing biological themes among gene clusters. OMICS-J Integr Biol, 2012, 16: 284-287.","journal-title":"OMICS-J Integr Biol"},{"key":"CITATION16","doi-asserted-by":"publisher","first-page":"D607","DOI":"10.1093\/nar\/gky1131","volume":"47","author":"Szklarczyk D","year":"2019","unstructured":"Szklarczyk D, Gable AL, Lyon D, Junge A, Wyder S, Huerta-Cepas J, Simonovic M. STRING v11: protein\u2013protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res, 2019, 47: D607-D613.","journal-title":"Nucleic Acids Res"},{"key":"CITATION17","doi-asserted-by":"publisher","first-page":"W60","DOI":"10.1093\/nar\/gky311","volume":"46","author":"Franz M","year":"2018","unstructured":"Franz M, Rodriguez H, Lopes C, Zuberi K, Montojo J, Bader GD, Morris Q. GeneMANIA update 2018. Nucleic Acids Res, 2018, 46: W60-W64.","journal-title":"Nucleic Acids Res"},{"key":"CITATION18","doi-asserted-by":"publisher","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","volume":"6","author":"Gao J","year":"2013","unstructured":"Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, Sun Y. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal, 2013, 6: pl1.","journal-title":"Sci Signal"},{"key":"CITATION19","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.immuni.2013.10.003","volume":"39","author":"Bindea G","year":"2013","unstructured":"Bindea G, Mlecnik B, Tosolini M, Kirilovsky A, Waldner M, Obenauf AC, Angell H. Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. Immunity, 2013, 39: 782-795.","journal-title":"Immunity"},{"key":"CITATION20","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/ncomms3612","volume":"4","author":"Yoshihara K","year":"2013","unstructured":"Yoshihara K, Shahmoradgoli M, Mart\u00ednez E, Vegesna R, Kim H, Torres-Garcia W, Trevi\u00f1o V. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun, 2013, 4: 2612.","journal-title":"Nat Commun"},{"key":"CITATION21","doi-asserted-by":"publisher","first-page":"609","DOI":"10.2147\/IJGM.S344858","volume":"Volume 15","author":"Wei YG","year":"2022","unstructured":"Wei YG, Yang CK, Wei ZL, Liao XW, He YF, Zhou X, Huang HS. High-Mobility group AT-Hook 1 served as a prognosis biomarker and associated with immune infiltrate in hepatocellular carcinoma. Int J Gen Med, 2022, Volume 15: 609-621.","journal-title":"Int J Gen Med"},{"key":"CITATION22","doi-asserted-by":"publisher","first-page":"W214","DOI":"10.1093\/nar\/gkq537","volume":"38","author":"Warde-Farley D","year":"2010","unstructured":"Warde-Farley D, Donaldson SL, Comes O, Zuberi K, Badrawi R, Chao P, Franz M. The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function. Nucleic Acids Res, 2010, 38: W214-W220.","journal-title":"Nucleic Acids Res"},{"key":"CITATION23","doi-asserted-by":"publisher","first-page":"3590","DOI":"10.1182\/bloodadvances.2022007256","volume":"6","author":"Sala-Torra O","year":"2022","unstructured":"Sala-Torra O, Beppu LW, Abukar FA, Radich JP, Yeung CCS. TTMV- RARA fusion as a recurrent cause of AML with APL characteristics. Blood Adv, 2022, 6: 3590-3592.","journal-title":"Blood Adv"},{"key":"CITATION24","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/s41419-025-07777-9","volume":"16","author":"He C","year":"2025","unstructured":"He C, Xiong Y, Zeng Y, Feng J, Yan F, Zhang M, Tan Z. HDAC3-YY1-RAB5A axis remodels AML-supportive niche by modulating mitochondrial homeostasis in bone marrow stromal cells. Cell Death Dis, 2025, 16: 498.","journal-title":"Cell Death Dis"},{"key":"CITATION25","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/s41420-024-01940-5","volume":"10","author":"Wu W","year":"2024","unstructured":"Wu W, Jiang Y, Xing D, Zhai Y, Sun H, He X, Luo K. The epigenetic regulators EP300\/CREBBP represent promising therapeutic targets in MLL-rearranged acute myeloid leukemia. Cell Death Discov, 2024, 10: 206.","journal-title":"Cell Death Discov"},{"key":"CITATION26","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"Dixon SJ","year":"2012","unstructured":"Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, Patel DN. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell, 2012, 149: 1060-1072.","journal-title":"Cell"},{"key":"CITATION27","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1046\/j.1365-2141.2001.03065.x","volume":"115","author":"Kollia P","year":"2001","unstructured":"Kollia P, Stavroyianni N, Stamatopoulos K, Zoi K, Viniou N, Mantzourani M, Noguchi CT. Molecular analysis of transferrin receptor mRNA expression in acute myeloid leukaemia. Br J Haematol, 2001, 115: 19-24.","journal-title":"Br J Haematol"},{"key":"CITATION28","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1038\/s41375-024-02169-y","volume":"38","author":"Yi W","year":"2024","unstructured":"Yi W, Zhang J, Huang Y, Zhan Q, Zou M, Cheng X, Zhang X. Ferritin-mediated mitochondrial iron homeostasis is essential for the survival of hematopoietic stem cells and leukemic stem cells. Leukemia, 2024, 38: 1003-1018.","journal-title":"Leukemia"},{"key":"CITATION29","doi-asserted-by":"publisher","first-page":"1275774","DOI":"10.3389\/fmolb.2023.1275774","volume":"10","author":"Zhang H","year":"2023","unstructured":"Zhang H, Sun C, Sun Q, Li Y, Zhou C, Sun C. Susceptibility of acute myeloid leukemia cells to ferroptosis and evasion strategies. Front Mol Biosci, 2023, 10: 1275774.","journal-title":"Front Mol Biosci"},{"key":"CITATION30","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1182\/blood.2024026040","volume":"145","author":"He L","year":"2025","unstructured":"He L, Zhao T, Leong WZ, Sharda A, Mayerhofer C, Mei S, Bonilla GM. PSTK inhibition activates cGAS-STING, precipitating ferroptotic cell death in leukemic stem cells. Blood, 2025, 145: 1903-1914.","journal-title":"Blood"},{"key":"CITATION31","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/s12943-025-02394-8","volume":"24","author":"Ye W","year":"2025","unstructured":"Ye W, Zhao Y, Zhou Y, Huang J, He X, Ma Z, Huang X. NSUN2-mediated cytosine-5 methylation of FSP1 protects acute myeloid leukemia cells from ferroptosis. Mol Cancer, 2025, 24: 201.","journal-title":"Mol Cancer"},{"key":"CITATION32","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.freeradbiomed.2025.03.031","volume":"233","author":"Shi J","year":"2025","unstructured":"Shi J, Cheng Y, Wang L, Xing W, Li Y, Sun X, Lv Y. SR-B1 deficiency suppresses progression in acute myeloid leukemia via ferroptosis and reverses resistance to venetoclax. Free Radical Biol Med, 2025, 233: 24-38.","journal-title":"Free Radical Biol Med"},{"key":"CITATION33","doi-asserted-by":"publisher","first-page":"646","DOI":"10.3724\/abbs.2025027","volume":"57","author":"Jia Y","year":"2025","unstructured":"Jia Y, Li L, Li Y, Zhu X, Wang H, Xu B, Li Q. Iron overload mediates cytarabine resistance in AML by inhibiting the TP53 signaling pathway. Acta Biochim Biophys Sin, 2025, 57: 646-655.","journal-title":"Acta Biochim Biophys Sin"},{"key":"CITATION34","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1200\/JCO.2016.71.2208","volume":"35","author":"Bullinger L","year":"2017","unstructured":"Bullinger L, D\u00f6hner K, D\u00f6hner H. Genomics of acute myeloid leukemia diagnosis and pathways. J Clin Oncol, 2017, 35: 934-946.","journal-title":"J Clin Oncol"},{"key":"CITATION35","doi-asserted-by":"publisher","first-page":"eadr0782","DOI":"10.1126\/sciimmunol.adr0782","volume":"10","author":"Maurer K","year":"2025","unstructured":"Maurer K, Park CY, Mani S, Borji M, Raths F, Gouin Iii KH, Penter L. Coordinated immune networks in leukemia bone marrow microenvironments distinguish response to cellular therapy. Sci Immunol, 2025, 10: eadr0782.","journal-title":"Sci Immunol"},{"key":"CITATION36","doi-asserted-by":"publisher","first-page":"6029","DOI":"10.1128\/MCB.16.11.6029","volume":"16","author":"L\u2019Horset F","year":"1996","unstructured":"L\u2019Horset F, Dauvois S, Heery DM, Cavaill\u00e8s V, Parker MG. RIP-140 interacts with multiple nuclear receptors by means of two distinct sites. Mol Cell Biol, 1996, 16: 6029-6036.","journal-title":"Mol Cell Biol"},{"key":"CITATION37","unstructured":"Chan CM, Lykkesfeldt AE, Parker MG, Dowsett M. Expression of nuclear receptor interacting proteins TIF-1, SUG-1, receptor interacting protein 140, and corepressor SMRT in tamoxifen-resistant breast cancer.  Clin Cancer Res  1999, 5: 3460\u20133467."},{"key":"CITATION38","doi-asserted-by":"publisher","first-page":"4449","DOI":"10.3390\/cancers13174449","volume":"13","author":"Palassin P","year":"2021","unstructured":"Palassin P, Lapierre M, Pyrdziak S, Wagner A, Stehle R, Corsini C, Duffour J. A truncated NRIP1 mutant amplifies microsatellite instability of colorectal cancer by regulating MSH2\/MSH6 expression, and is a prognostic marker of stage III tumors. Cancers, 2021, 13: 4449.","journal-title":"Cancers"},{"key":"CITATION39","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.1111\/cas.15772","volume":"114","author":"Ji X","year":"2023","unstructured":"Ji X, Lv C, Huang J, Dong W, Sun W, Zhang H. ALKBH5-inducedcircular RNA NRIP1 promotes glycolysis in thyroid cancer cells by targeting PKM2. Cancer Sci, 2023, 114: 2318-2334.","journal-title":"Cancer Sci"},{"key":"CITATION40","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1126\/science.1235122","volume":"339","author":"Vogelstein B","year":"2013","unstructured":"Vogelstein B, Papadopoulos N, Velculescu VE, Zhou S, Diaz Jr. LA, Kinzler KW. Cancer genome landscapes. Science, 2013, 339: 1546-1558.","journal-title":"Science"},{"key":"CITATION41","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-019-1170-y","volume":"569","author":"Wang W","year":"2019","unstructured":"Wang W, Green M, Choi JE, Gij\u00f3n M, Kennedy PD, Johnson JK, Liao P. CD8+ T cells regulate tumour ferroptosis during cancer immunotherapy. Nature, 2019, 569: 270-274.","journal-title":"Nature"},{"key":"CITATION42","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/s41422-019-0263-3","volume":"30","author":"Lei G","year":"2020","unstructured":"Lei G, Zhang Y, Koppula P, Liu X, Zhang J, Lin SH, Ajani JA. The role of ferroptosis in ionizing radiation-induced cell death and tumor suppression. Cell Res, 2020, 30: 146-162.","journal-title":"Cell Res"},{"key":"CITATION43","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/j.ccell.2017.05.010","volume":"31","author":"Abril-Rodriguez G","year":"2017","unstructured":"Abril-Rodriguez G, Ribas A. SnapShot: immune checkpoint inhibitors. Cancer Cell, 2017, 31: 848-848.e1.","journal-title":"Cancer Cell"},{"key":"CITATION44","doi-asserted-by":"publisher","first-page":"1429855","DOI":"10.3389\/fimmu.2024.1429855","volume":"15","author":"Zhao Z","year":"2024","unstructured":"Zhao Z, Wang D, Sheng X, Li S, Liu T, Chang M, Feng L. Identification and validation of BATF as a prognostic biomarker and regulator of immune cell infiltration in acute myeloid leukemia. Front Immunol, 2024, 15: 1429855.","journal-title":"Front Immunol"},{"key":"CITATION45","doi-asserted-by":"publisher","first-page":"978786","DOI":"10.3389\/fcell.2022.978786","volume":"10","author":"Su X","year":"2022","unstructured":"Su X, Ma G, Bai X, Zhang J, Li M, Zhang F, Sun T. The prognostic marker FLVCR2 associated with tumor progression and immune infiltration for acute myeloid leukemia. Front Cell Dev Biol, 2022, 10: 978786.","journal-title":"Front Cell Dev Biol"},{"key":"CITATION46","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.3724\/abbs.2024112","volume":"56","author":"Liu J","year":"2024","unstructured":"Liu J, Gu J. Importance of PTM of FLT3 in acute myeloid leukemia. Acta Biochim Biophys Sin, 2024, 56: 1199-1207.","journal-title":"Acta Biochim Biophys Sin"},{"key":"CITATION47","doi-asserted-by":"publisher","first-page":"3149","DOI":"10.1016\/j.apsb.2025.04.001","volume":"15","author":"Liu B","year":"2025","unstructured":"Liu B, Deng WZ, Hu WH, Lu RX, Zhang QY, Gao CF, Huang XJ. Psychological stress-activated NR3C1\/NUPR1 axis promotes ovarian tumor metastasis. Acta Pharm Sin B, 2025, 15: 3149-3162.","journal-title":"Acta Pharm Sin B"},{"key":"CITATION48","doi-asserted-by":"publisher","first-page":"e2409050","DOI":"10.1002\/advs.202409050","volume":"12","author":"Yu J","year":"2025","unstructured":"Yu J, Chen M, Sang Q, Li F, Xu Z, Yu B, He C. Super-enhancer activates master transcription factor NR3C1 expression and promotes 5-FU resistance in gastric cancer. Adv Sci, 2025, 12: e2409050.","journal-title":"Adv Sci"},{"key":"CITATION49","doi-asserted-by":"publisher","first-page":"4295","DOI":"10.1097\/JS9.0000000000002531","volume":"111","author":"Shi P","year":"2025","unstructured":"Shi P, Hu B, Liu Y, Li X, Li W, Huang C, Jiang M. Long non-coding RNA NORAD suppresses erastin-induced ferroptosis in breast cancer by upregulating SLC7A11 via targeting the FUS\/NR3C1 axis: experimental studies. Int J Surg, 2025, 111: 4295-4313.","journal-title":"Int J Surg"},{"key":"CITATION50","doi-asserted-by":"publisher","first-page":"1075431","DOI":"10.3389\/fendo.2022.1075431","volume":"13","author":"Chen J","year":"2022","unstructured":"Chen J, Wang G, Zhang D, Luo X, Zhang D, Zhang Y. Construction of novel hypoxia-related gene model for prognosis and tumor microenvironment in endometrial carcinoma. Front Endocrinol, 2022, 13: 1075431.","journal-title":"Front Endocrinol"},{"key":"CITATION51","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1158\/0008-5472.CAN-23-3942","volume":"84","author":"Liu D","year":"2024","unstructured":"Liu D, Wei B, Liang L, Sheng Y, Sun S, Sun X, Li M. The circadian clock component RORA increases immunosurveillance in melanoma by inhibiting PD-L1 expression. Cancer Res, 2024, 84: 2265-2281.","journal-title":"Cancer Res"},{"key":"CITATION52","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s41420-024-01800-2","volume":"10","author":"Yu X","year":"2024","unstructured":"Yu X, Wang Y, Tan J, Li Y, Yang P, Liu X, Lai J. Inhibition of NRF2 enhances the acute myeloid leukemia cell death induced by venetoclax via the ferroptosis pathway. Cell Death Discov, 2024, 10: 35.","journal-title":"Cell Death Discov"}],"container-title":["Acta Biochimica et Biophysica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.sciengine.com\/doi\/pdf\/63101E1B4A8D4D809DE56CD4FF0883BA","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.sciengine.com\/doi\/10.3724\/abbs.2025197","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.sciengine.com\/doi\/pdf\/63101E1B4A8D4D809DE56CD4FF0883BA","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T08:27:54Z","timestamp":1770884874000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.sciengine.com\/doi\/10.3724\/abbs.2025197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,4]]},"references-count":52,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,11,4]]},"published-print":{"date-parts":[[2026,2,1]]}},"URL":"https:\/\/doi.org\/10.3724\/abbs.2025197","relation":{},"ISSN":["1672-9145"],"issn-type":[{"value":"1672-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11,4]]}}}